Valeo Pharma Inc
TSX:VPH
Valeo Pharma Inc
Depreciation & Amortization
Valeo Pharma Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Valeo Pharma Inc
TSX:VPH
|
Depreciation & Amortization
CA$2.6m
|
CAGR 3-Years
84%
|
CAGR 5-Years
126%
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
Depreciation & Amortization
$2.9m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
41%
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Depreciation & Amortization
CA$49.9m
|
CAGR 3-Years
17%
|
CAGR 5-Years
90%
|
CAGR 10-Years
N/A
|
Spectral Medical Inc
TSX:EDT
|
Depreciation & Amortization
CA$220k
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-1%
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
Depreciation & Amortization
$1.2m
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
V
|
Vext Science Inc
CNSX:VEXT
|
Depreciation & Amortization
$9.6m
|
CAGR 3-Years
65%
|
CAGR 5-Years
76%
|
CAGR 10-Years
N/A
|
See Also
What is Valeo Pharma Inc's Depreciation & Amortization?
Depreciation & Amortization
2.6m
CAD
Based on the financial report for Oct 31, 2023, Valeo Pharma Inc's Depreciation & Amortization amounts to 2.6m CAD.
What is Valeo Pharma Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
126%
Over the last year, the Depreciation & Amortization growth was 85%. The average annual Depreciation & Amortization growth rates for Valeo Pharma Inc have been 84% over the past three years , 126% over the past five years .